The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical implications of tumor-based next-generation sequencing in ovarian cancer.
 
Katherine Foster
Research Funding - Karyopharm Therapeutics (Inst)
 
Kenna R. Shaw
Consulting or Advisory Role - Guidepoint Global
Research Funding - Guardant Health (Inst); Philips Healthcare (Inst); Tempus (Inst)
 
Jeff Jin
No Relationships to Disclose
 
Shannon Neville Westin
Consulting or Advisory Role - Agenus; AstraZeneca; BioAscent; Clovis Oncology; Curio Science; Curio Science; Eisai; EQRX; Genentech; Gerson Lehrman Group; GlaxoSmithKline; Immunogen; Lilly; Medscape; Merck; Mereo BioPharma; Mersana; OncLive; Roche; Targeted Oncology; Vaniam Group; Vincerx Pharma; Zentalis
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); Cotinga Pharmaceuticals (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Mereo BioPharma (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Roche/Genentech (Inst)
 
Timothy A. Yap
Employment - MD Anderson Cancer Center
Stock and Other Ownership Interests - Seagen
Consulting or Advisory Role - Abbvie; Acrivon Therapeutics; Adagene; Aduro Biotech; Almac Group; Amphista Therapeutics; Artios; AstraZeneca; Athenahealth; Atrin Pharmaceuticals; Avoro Capital Advisors; Axiom Biotechnologies; Baptist Health; Bayer; BeiGene; Boxer; Bristol-Myers Squibb; C4 Therapeutics; Calithera Biosciences; Cancer Research UK; Clovis Oncology; Cybrexa Therapeutics; Diffusion Pharmaceuticals; EMD Serono; F-Star; Genmab; Gerson Lehrman Group; GlaxoSmithKline; Glenmark; Globe Life Science; Guidepoint Global; Gustave Roussy Cancer Center; I-Mab; Idience; Ignyta; ImmuneSensor Therapeutics; Intellisphere; Janssen; Kyn therapeutics; MEI Pharma; Merck; Mereo BioPharma; Natera; Nexys Therapeutics; Novocure; OncoSec; Ono Pharmaceutical; Oregon Health & Science University (OHSU); Pegascy; PER; Pfizer; Piper Sandler; ProLynx; Repare Therapeutics; resTORbio; Roche; Schrodinger; Theragnostics; Varian Medical Systems; Versant Health; Vibliome Therapeutics; Xinthera; Zai Lab; ZielBio
Research Funding - Acrivon Therapeutics (Inst); Artios (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); BioNTech (Inst); Blueprint Medicines (Inst); BMS (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Cyteir (Inst); EMD Serono (Inst); F-Star (Inst); Forbius (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Haihe Biopharma (Inst); ImmuneSensor Therapeutics (Inst); Ionis Pharmaceuticals (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Karyopharm Therapeutics (Inst); KSQ Therapeutics (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Ribon Therapeutics (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Scholar Rock (Inst); Seagen (Inst); Tesaro (Inst); Vivace Therapeutics (Inst); Zenith (Inst)
 
Amir A. Jazaeri
Stock and Other Ownership Interests - Avenge Bio
Honoraria - Gerson Lehrman Group; Guidepoint Global; Mosaic Research Management
Consulting or Advisory Role - Agenus; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; integrity Continuing Education; Iovance Biotherapeutics; Macrogenics; NuProbe; twoXAR
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); ZIOPHARM Oncology (Inst)
 
Jose A. Rauh-Hain
No Relationships to Disclose
 
Sanghoon Lee
No Relationships to Disclose
 
Bryan M. Fellman
No Relationships to Disclose
 
Zhenlin Ju
No Relationships to Disclose
 
Nicole D. Fleming
Consulting or Advisory Role - GlaxoSmithKline; Immunogen; Pfizer; Tesaro
 
Anil K Sood
Employment - Amgen (I)
Stock and Other Ownership Interests - Bio-Path Holdings, Inc
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - GlaxoSmithKline; Iylon; KIYATEC; Merck; Merck
Research Funding - MTrap
Patents, Royalties, Other Intellectual Property - EGFL6 antibody royalty payment; SiRNA delivery (patents on DOPC, rHDL)
(OPTIONAL) Uncompensated Relationships - Elsevier